×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – August 15, 2023

  • August 15, 2023
Subscribe to receive our Event Driven Monitor by email every morning before the market opens. Merger Arbitrage ZYNE: Zynerba Pharmaceuticals to be acquired by Harmony Biosciences Holdings (HRMY) for $60 million. Under the terms of the agreement, Harmony will commence a tender offer to acquire all outstanding shares of Zynerba for a purchase price of $1.1059 per share in cash, plus one non-tradeable contingent value right (CVR) per share, representing the right to receive potential additional payments of up to $140 million in the aggregate, subject to the achievement of certain clinical, regulatory and sales milestones. SAL: NBT Bancorp (NBTB) completed the acquisition of Salisbury Bancorp (SAL). You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here. Deals In The Works DLO: Bloomberg reported DLocal (DLO) a provider of payments services to businesses in emerging markets, is exploring options including a potential sale. X: Esmark announced a voluntary public cash and exchange offer for all issued and outstanding shares in U.S. Steel Corporation (X) for $35 USD per share. LL: LL Flooring Holdings (LL) announces exploration of strategic alternatives. Insider Purchases SRPT: Michael Andrew Chambers, a Director of biotech...

Only plus or premium subscribers can access this post. Subscribe today.